| |
| Issue |
Title |
| |
| No 2 (2022) |
Development and validation of a method for porphyrins quantification using HPLC-UV in urine |
Abstract
PDF (Rus)
|
|
D. A. Kildyushkin, A. E. Petukhov, E. A. Litvin |
| |
| No 2 (2022) |
Development of approaches for studying the biodistribution of a bicistronic therapeutic plasmid construct in the mouse body |
Abstract
PDF (Rus)
|
|
S. S. Dzhauari, M. N. Karagyaur, V. Yu. Balabanyan, M. N. Skryabina, A. L. Primak, D. V. Stambolsky |
| |
| No 2 (2021) |
Determination of a novel anticonvulsant drug GIZh-290 in rat plasma by liquid chromatography–tandem mass spectrometry |
Abstract
PDF (Rus)
|
|
P. O. Bochkov, I. P. Khrustova, A. A. Litvin, G. B. Kolyvanov, R. V. Shevchenko, V. P. Zherdev |
| |
| No 2 (2021) |
An approach to the quantitative determination of endogenous substances in biological fluids by a chromatographic method using a mathematical apparatus |
Abstract
PDF (Rus)
|
|
V. V. Smirnov, L. M. Krasnykh, G. V. Ramenskaya, S. B. Kazanbekov |
| |
| No 1 (2021) |
Development and validation of the method for the quantitative determination of methotrexate in a transport medium by HPLC-MS/MS |
Abstract
PDF (Rus)
|
|
P. Yu. Mylnikov, Yu. Tranova, A. V. Shchulkin, E. N. Yakusheva |
| |
| No 2 (2017) |
Design of HPLC methods of fexofenadine quantitative analysis in blood plasma |
Abstract
PDF (Rus)
|
|
E. N. Yakusheva, I. V. Chernykh, A. V. Shulkin, M. V. Gatsanoga |
| |
| 1 - 6 of 6 Items |
|
